Viewing Study NCT00988832


Ignite Creation Date: 2025-12-24 @ 9:59 PM
Ignite Modification Date: 2026-07-12 @ 10:59 AM
Study NCT ID: NCT00988832
Status: COMPLETED
Last Update Posted: 2015-09-02
First Post: 2009-10-01
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: An Audit of Patients With Crohn's Disease Treated With Infliximab (P06066)
Sponsor: Merck Sharp & Dohme LLC
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: P06066
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators